Pay in 4 interest-free payments of $6.02 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
The price of GLP-1 drugs has attracted the scrutiny of lawmakers, and Novo Nordisk's chief executive Lars Fruergaard Jrgensen has agreed to appear at a Senate hearing next week to defend the pricing of the group's semaglutide-based therapies
Relationship of ketamine's antidepressant and psychotomimetic effects in unipolar depression
As your body changes, so does your protocol
The industry landscape has changed dramatically, with Pfizer's two core GLP-1R small molecule agonists, Danuglipron and Lotiglipron, both failing, while Structure Therapeutics' stock experienced a rollercoaster-like fluctuation, instilling a sense of panic among investors
US$ 28.55
US$ 22.29
US$ 21.07
US$ 26.81
US$ 27.50
US$ 27.02
